BIOMAT Database Logo BIOMAT Database Logo

Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria). 1991

F Bonifazi, and L Antonicelli, and M B Bilò, and S Pucci, and I H Taylor, and A W Wheeler, and L J Youlten
Servizio Allergologia Respiratoria, Ospedale Generale Umberto I, Ancona, Italy.

Thirty patients suffering from allergy to Parietaria pollen were treated with either a new tyrosine-adsorbed allergoid of Parietaria judaica pollen (Pollinex Parietaria) or a commercially available alum-adsorbed extract (Alavac) as control. A reduced response to nasal provocation was seen in 7 out of 11 patients following treatment with Pollinex and 1 out of 10 after control treatment. 9 out of 11 and 3 out of 10, respectively, showed reduced skin test activity. Patients who received Pollinex tended to have fewer nasal symptoms during the pollen season. Pollinex induced larger increases in P. judaica-specific IgG antibody than did the control product. Side effects of therapy were similar between the two groups of patients. Pollinex Parietaria thus shows good potential for the control of allergy to Parietaria pollen.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007163 Immunosorbent Techniques Techniques for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody. Immunoadsorbent Techniques,Immunoadsorbent Technics,Immunosorbent Technics,Immunoadsorbent Technic,Immunoadsorbent Technique,Immunosorbent Technic,Immunosorbent Technique,Technic, Immunoadsorbent,Technic, Immunosorbent,Technics, Immunoadsorbent,Technics, Immunosorbent,Technique, Immunoadsorbent,Technique, Immunosorbent,Techniques, Immunoadsorbent,Techniques, Immunosorbent
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D010940 Plant Proteins Proteins found in plants (flowers, herbs, shrubs, trees, etc.). The concept does not include proteins found in vegetables for which PLANT PROTEINS, DIETARY is available. Plant Protein,Protein, Plant,Proteins, Plant
D011058 Pollen The fertilizing element of plants that contains the male GAMETOPHYTES. Male Gametes, Plant,Male Gametophytes,Microspores, Plant,Plant Microspores,Pollen Grains,Gamete, Plant Male,Gametes, Plant Male,Gametophyte, Male,Gametophytes, Male,Grain, Pollen,Grains, Pollen,Male Gamete, Plant,Male Gametophyte,Microspore, Plant,Plant Male Gamete,Plant Male Gametes,Plant Microspore,Pollen Grain
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females

Related Publications

F Bonifazi, and L Antonicelli, and M B Bilò, and S Pucci, and I H Taylor, and A W Wheeler, and L J Youlten
Pollinex Parietaria (Bencard Parietaria), a new allergoid for treatment of patients sensitive to Parietaria pollen.
April 1991, Journal of investigational allergology & clinical immunology,
F Bonifazi, and L Antonicelli, and M B Bilò, and S Pucci, and I H Taylor, and A W Wheeler, and L J Youlten
[Hyposensitization in pollinosis. Results of a 3-year controlled study with 2 depot-allergoid grass pollen extracts: aluminum hydroxide-adsorbed allergoid and tyrosine-adsorbed allergoid].
April 1990, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
F Bonifazi, and L Antonicelli, and M B Bilò, and S Pucci, and I H Taylor, and A W Wheeler, and L J Youlten
Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study.
January 1997, Allergy,
F Bonifazi, and L Antonicelli, and M B Bilò, and S Pucci, and I H Taylor, and A W Wheeler, and L J Youlten
Parietaria sublingual allergoid immunotherapy with a co-seasonal treatment schedule.
January 2008, Allergologia et immunopathologia,
F Bonifazi, and L Antonicelli, and M B Bilò, and S Pucci, and I H Taylor, and A W Wheeler, and L J Youlten
[Leukocyte migration inhibition test in patients with pollen-induced asthma and the results of hyposensitization therapy with Pollinex].
March 1984, Pneumonologia polska,
F Bonifazi, and L Antonicelli, and M B Bilò, and S Pucci, and I H Taylor, and A W Wheeler, and L J Youlten
[Specific desensitizing therapy of patients sensitive to Parietaria officinalis].
January 1969, Folia allergologica,
F Bonifazi, and L Antonicelli, and M B Bilò, and S Pucci, and I H Taylor, and A W Wheeler, and L J Youlten
Specific hyposensitization in patients allergic to Parietaria officinalis pollen allergen.
January 1994, Journal of investigational allergology & clinical immunology,
F Bonifazi, and L Antonicelli, and M B Bilò, and S Pucci, and I H Taylor, and A W Wheeler, and L J Youlten
A novel microcrystalline tyrosine-adsorbed, mite-allergoid subcutaneous immunotherapy: 1-year follow-up report.
October 2016, Immunotherapy,
F Bonifazi, and L Antonicelli, and M B Bilò, and S Pucci, and I H Taylor, and A W Wheeler, and L J Youlten
[Advantages of hyposensitization with a high dose of allergoid in pollen allergy].
January 1983, Klinische Padiatrie,
F Bonifazi, and L Antonicelli, and M B Bilò, and S Pucci, and I H Taylor, and A W Wheeler, and L J Youlten
Prolonged interval hyposensitization therapy in hymenoptera-sensitive patients.
September 1975, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!